Detailed description page of SalivaDB

This page displays user query in tabular form.

SAL_24803 details
Primary information
SALIDSAL_24803
Biomarker namehsa-miR-29b-3p
Biomarker TypeDiagnostic
Sampling MethodOPMD patients were clinically diagnosed by the neurologist based on the common clinical OPMD symptoms. OPMD was genetically confirmed using a genetic test. Patients with OPMD-like symptoms without a genetic confirmation were excluded.
Collection MethodSaliva was collected in RNeasy Protect Saliva Mini Kit (Qiagen).
Analysis MethodqRT-PCR
Collection SiteSaliva
Disease CategoryGenetic Disorder
Disease/ConditionOculopharyngeal Muscular Dystrophy (OPMD)
Disease SubtypeNA
Fold Change/ ConcentrationNA
Up/DownregulatedDownregulated
ExosomalNA
OrganismHomo sapiens
PMID32842713
Year of Publication2020
Biomarker IDhsa-miR-29b-3p
Biomarker CategorymiRNA
SequenceUAGCACCAUUUGAAAUCAGUGUU
Title of studyAge-Associated Salivary MicroRNA Biomarkers for Oculopharyngeal Muscular Dystrophy
Abstract of studySmall non-coding microRNAs (miRNAs) are involved in the regulation of mRNA stability. Their features, including high stability and secretion to biofluids, make them attractive as potential biomarkers for diverse pathologies. This is the first study reporting miRNA as potential biomarkers for oculopharyngeal muscular dystrophy (OPMD), an adult-onset myopathy. We hypothesized that miRNA that is differentially expressed in affected muscles from OPMD patients is secreted to biofluids and those miRNAs could be used as biomarkers for OPMD. We first identified candidate miRNAs from OPMD-affected muscles and from muscles from an OPMD mouse model using RNA sequencing. We then compared the OPMD-deregulated miRNAs to the literature and, subsequently, we selected a few candidates for expression studies in serum and saliva biofluids using qRT-PCR. We identified 126 miRNAs OPMD-deregulated in human muscles, but 36 deregulated miRNAs in mice only (pFDR < 0.05). Only 15 OPMD-deregulated miRNAs overlapped between the in humans and mouse studies. The majority of the OPMD-deregulated miRNAs showed opposite deregulation direction compared with known muscular dystrophies miRNAs (myoMirs), which are associated. In contrast, similar dysregulation direction was found for 13 miRNAs that are common between OPMD and aging muscles. A significant age-association (p < 0.05) was found for 17 OPMD-deregulated miRNAs (13.4%), whereas in controls, only six miRNAs (1.4%) showed a significant age-association, suggesting that miRNA expression in OPMD is highly age-associated. miRNA expression in biofluids revealed that OPMD-associated deregulation in saliva was similar to that in muscles, but not in serum. The same as in muscle, miRNA expression levels in saliva were also found to be associated with age (p < 0.05). Moreover, the majority of OPMD-miRNAs were found to be associated with dysphagia as an initial symptom. We suggest that levels of specific miRNAs in saliva can mark muscle degeneration in general and dysphagia in OPMD.